Jan 13 (Reuters) - Drugmakers will ask the U.S.

government to pause price negotiations for prescription drugs,

Bloomberg News reported on Monday, citing Eli Lilly's ( LLY )

CEO David Ricks.

Ricks said at the JPMorgan Healthcare Conference that the

government needs to "fix" the Inflation Reduction Act (IRA)

before the second round of talks over price cuts, the report

added.

The outgoing administration is planning to release a list of

the next set of drugs eligible for negotiation before leaving

office, Bloomberg reported, citing a person familiar with the

matter.

Lilly did not immediately respond to a Reuters request for

comment.

Under the IRA, President Joe Biden's signature

legislation, prices for 10 highly popular prescription drugs

used by Medicare will be cut by 38% to 79% in 2026.

Regulators are due to announce the list of 15 more drugs

by February.